Q4: 2026-02-17 Earnings Summary
EPS of $0.60 beats by $0.19
| Revenue of $226.20M (5.89% Y/Y) beats by $241.00K
USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call February 18, 2026 11:00 AM EST
Company Participants
Andrew Masuda – Director of Investor Relations
Kevin Guest – CEO & Executive Chairman
G. Hekking – Chief Financial Officer
Walter Noot – Chief Operating Officer
Brent Neidig – Chief Commercial Officer
Kathryn Armstrong – Chief Scientific Officer
Conference Call Participants
Anthony Lebiedzinski – Sidoti & Company, LLC
Ivan Feinseth – Tigress Financial Partners LLC, Research Division
Presentation
Operator
Greetings. Welcome to the USANA Health Sciences Fourth Quarter and Fiscal Year 2025 Earnings Call. [Operator Instructions] Please note, this conference is being recorded.
At this time, I’ll now turn the conference over to Andrew Masuda, Director of Investor Relations. Thank you, Andrew. You may now begin.
Andrew Masuda
Director of Investor Relations
Thanks, Rob, and good morning, everyone. We appreciate you joining us to review our fourth quarter and fiscal year 2025 results. Today’s conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website.
As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ perhaps materially from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2026, uncertainty related to the economic and operating environment around the world and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC.
I’m joined by our Chairman and Chief Executive Officer, Kevin Guest; our Chief Financial Officer, Doug
